Home > Insider Trading > Filing (0001140361-24-039822)

Filing Details

Accession Number:: 0001140361-24-039822
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-08-30 21:05:28
Reporting Period:: 2024-08-30

Accepted Time:: 2024-08-30 21:05:28
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1368514	Adma Biologics Inc.	ADMA	Biological Products, (No Disgnostic Substances) (2836)	562590442

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
2017423	M. Kaitlin Kestenberg-Messina	C/O Adma Biologics, Inc. 5800 Park Of Commerce Blvd. Nw, Boca Raton FL 33487	Coo And Svp, Compliance	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2024-08-30	8,125	$2.35	457,213	No	4	M	Direct
Common Stock	Acquisiton	2024-08-30	4,375	$2.59	461,588	No	4	M	Direct
Common Stock	Acquisiton	2024-08-30	6,650	$5.94	468,238	No	4	M	Direct
Common Stock	Acquisiton	2024-08-30	5,000	$4.72	473,238	No	4	M	Direct
Common Stock	Disposition	2024-08-30	24,150	$16.90	449,088	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock	Disposition	2024-08-30	8,125	$2.35	8,125	$2.35
Common Stock	Common Stock	Disposition	2024-08-30	4,375	$2.59	4,375	$2.59
Common Stock	Common Stock	Disposition	2024-08-30	6,650	$5.94	6,650	$5.94
Common Stock	Common Stock	Disposition	2024-08-30	5,000	$4.72	5,000	$4.72

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
3,750	2031-02-25	No	4	M	Direct
0	2030-03-10	No	4	M	Direct
0	2028-10-09	No	4	M	Direct
0	2028-05-03	No	4	M	Direct

Footnotes

The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $16.72 to $17.02. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Includes, as of the transaction date (i) 192,320 unvested RSUs granted on April 1, 2024, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (ii) 22,500 unvested RSUs granted on July 24, 2023, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (iii) 71,250 unvested RSUs granted on March 6, 2023, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (iv) 20,000 unvested RSUs granted on March 7, 2022, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to
(continued from footnote 2) the reporting person's continued service as of the applicable vesting date; (v) 12,500 unvested RSUs granted on September 28, 2021, which are the remaining unvested RSUs of the 100,000 RSUs granted on September 28, 2021 which vest on a schedule of 50% vesting on December 31, 2022 and the remaining vesting quarterly from March 31, 2023 to December 31, 2024, subject to the reporting person's continued service as of the applicable vesting date; (vi) 5,000 unvested RSUs granted on February 25, 2021, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; and (vii) 125,518 shares of common stock owned by the reporting person, which reflects the prior net settlement upon vesting of previously granted RSUs after the withholding of shares to cover applicable taxes.
These options were granted on February 25, 2021 and will vest over four years with 25% of the shares of common stock underlying the options vesting on the one-year anniversary of the date of grant and the remaining 75% of such shares vesting monthly in equal installments over the next three years thereafter, subject to the reporting person's continued service as of the applicable vesting date, and will become fully vested on February 25, 2025.
These options were granted on March 10, 2020 and are fully vested.
These options were granted on October 9, 2018 and are fully vested.
These options were granted on May 3, 2018 and are fully vested.